Evidence map›Paper›PMID 31971330›Full record

ArticleJournal of biomedical materials research. Part A2020

Self-healing injectable gelatin hydrogels for localized therapeutic cell delivery.

Arbel M Sisso, Mary O Boit, Cole A DeForest

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Biomaterial Scaffolds for Periodontal Tissue Engineering.Journal of functional biomaterials · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. The Utilisation of Hydrogels for iPSC-Cardiomyocyte Research.International journal of molecular sciences · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Arbel M SissoDepartment of Bioengineering, University of Washington, Seattle, Washington.
Mary O BoitDepartment of Chemical Engineering, University of Washington, Seattle, Washington.ORCID 0000-0001-9990-6950
Cole A DeForestDepartment of Bioengineering, University of Washington, Seattle, Washington.ORCID 0000-0003-0337-3577
University of Washington · USCalifornia Institute for Regenerative Medicine · US

Funding

Bioengineering Cardiovascular Training GrantT32EB001650 · NIBIB · UNIVERSITY OF WASHINGTON · PI REGNIER, MICHAEL · 2004 to 2019
$3.6M
NIBIB NIH HHS T32 EB001650
6 · The paper itself

Abstract

Self-healing injectable hydrogel biomaterials uniquely enable precise therapeutic deposition and deployment at specific bodily locations through versatile and minimally invasive processes that can preserve cargo integrity and cell viability. Despite the distinct advantages that injectable hydrogels offer in tissue engineering and therapeutic delivery, exceptionally few have been created using components naturally present in the cellular niche. In this work, we introduce a shear-thinning hydrogel based on guest-host complexation of gelatin. As a biocompatible, biodegradable, and nonimmunogenic biopolymer derived from the most abundant extracellular matrix protein (collagen), gelatin offers great utility as the structural component of biomaterials. Taking advantage of reversible guest-host interactions between β-cyclodextrin (CD) and adamantane (AD) on modified gelatins, we report the first strategy to afford a self-healing material based solely on a functionalized extracellular matrix protein. By varying the initial material formulation, hydrogels were synthesized with variable moduli and shear-thinability across a broad range. Gels were demonstrated to exhibit shear-thinning and self-healing properties, supporting protection of clinically relevant stem-cell-derived cardiomyocytes during injection. These materials are expected to expand clinical opportunities in cell delivery for in vivo tissue regeneration.

Indexed as

beta-CyclodextrinsBiocompatible MaterialsCell EncapsulationCell LineGelatinHumansHydrogelsInjectionsMyocytes, CardiacTissue Engineeringbeta-CyclodextrinsbetadexBiocompatible MaterialsGelatinHydrogelscell deliveryguest-host complexationhydrogelinjectableshear-thinning

Identifiers

PMID31971330
PMCPMC8285007
OpenAlexW3001358251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.